Hessel, Anthony L. http://orcid.org/0000-0003-4278-4221
Kuehn, Michel N.
Han, Seong-Won
Ma, Weikang http://orcid.org/0000-0001-9535-7114
Irving, Thomas C.
Momb, Brent A.
Song, Taejeong http://orcid.org/0000-0001-6648-1263
Sadayappan, Sakthivel http://orcid.org/0000-0003-2006-7678
Linke, Wolfgang A. http://orcid.org/0000-0003-0801-3773
Palmer, Bradley M. http://orcid.org/0000-0002-4388-3160
Article History
Received: 17 November 2023
Accepted: 29 April 2024
First Online: 27 May 2024
Competing interests
: The authors declare the following competing interests: W.M. and T.I. provides consulting and collaborative research studies to Edgewise Therapeutics Inc. A.L.H. and M.K. are owners of Accelerated Muscle Biotechnologies Consultants LLC, and S.S. provides consulting and collaborative research studies to the Leducq Foundation (CURE-PLAN), Red Saree Inc., Greater Cincinnati Tamil Sangam, Novo Nordisk, Pfizer, AavantiBio, Affinia Therapeutics Inc., Cardiocare Genetics—Cosmogene Skincare Pvt Ltd., AstraZeneca, MyoKardia, Merck and Amgen, but such work is unrelated to the content of this article. The remaining authors declare no competing interests.